Miyatake, Daisuke
Shibata, Tomohisa
Shibata, Mai
Kaneko, Yuichiro
Oda, Kazuo
Nishimura, Tetsuya
Katashima, Masataka
Sekino, Hisakuni
Furihata, Kenichi
Urae, Akinori
Clinical trials referenced in this document:
Documents that mention this clinical trial
Pharmacokinetics and Safety of a Single Oral Dose of Peficitinib (ASP015K) in Japanese Subjects with Normal and Impaired Renal Function
https://doi.org/10.1007/s40261-019-00873-7
Funding for this research was provided by:
Astellas Pharma Inc.
Article History
First Online: 15 November 2019
Compliance with Ethical Standards
:
: This study was sponsored by Astellas Pharma Inc. Medical writing support was provided by Lisa O’Rourke, PhD, for Cello Health MedErgy (Europe) and funded by Astellas Pharma Inc.
: DM, TS, MS, YK, TN and MK are employees of Astellas Pharma Inc. KO is an employee of Astellas Research Institute of America LLC. HS, KF and AU have no conflicts of interest to declare.
: The study was reviewed and approved by the Institutional Review Board. The study was conducted in accordance with the International Conference on Harmonization (ICH) guidelines for Good Clinical Practice (GCP), applicable regulations, and guidelines governing clinical study conduct and the ethical principles that have their origin in the Declaration of Helsinki.
: Informed consent was obtained from all individual participants included in the study.